Abstract Purpose of Review The global outbreak of mpox has brought renewed attention to a
previously neglected disease which is particularly severe in people with underlying …

Monkeypox virus (MPXV) is a DNA virus belonging to the Orthopoxvirus genus within the
Poxviridae family which can cause a zoonotic infection. The unexpected non-endemic …

Background During the ongoing outbreak of clade II monkeypox virus (MPXV), many US
patients were prescribed tecovirimat, an antiviral drug that was made available under an …

The Mpox virus (MPXV) is the causative agent of human Mpox disease–a debilitating rash
illness similar to smallpox. Although Clade I MPXV has remained endemic to West and …

Monkeypox, now named mpox, has emerged as a significant public threat, as evidenced by
the 2022 outbreak affecting over seventy countries globally. This infectious disease presents …

The laboratory diagnosis of antiviral resistance is a quickly changing field due to new drug
availability, the sunsetting of older drugs, the development of novel technologies, rapid viral …

Objective The 2022 global mpox outbreak disproportionately impacted people living with
HIV. This review explores recent evidence on mpox in this group, focusing on clinical …

Background Mpox, caused by monkeypox virus (MPXV), was considered a rare zoonotic
disease before May 2022, when a global epidemic of cases in non-endemic countries led to …

Reports of tecovirimat-resistant mpox have emerged after widespread use of antiviral
therapy during the 2022 mpox outbreak. Optimal management of patients with persistent …

This severe monkeypox case described a 23-year-old male with advanced HIV-1 disease
presenting perirectal abscess, extensive anal ulcerative lesions requiring colostomy, and …